NiveshIQNiveshIQ
NSE: SANOFICONR  ·  FMCG

Sanofi Consumer Healthcare India Ltd.

₹4,724.10▲ ₹4.10 (+0.09%)
Volume: 3,938Day Range: ₹4,637.30 – ₹4,799.9052W Range: ₹3,975.00 – ₹5,894.50
Price Chart  ·  Daily closes
1Y 6M 3M 1M 1W 1D
⚡ Intelligence Signals 5 active
🟢 Bullish Earnings Catalyst 📊 RS Laggard (5D) 🔄 Sector Sweep ⚡ Signals Aligned 📉 Pullback

NiveshIQ has detected 5 active signals on SANOFICONR. Sign up free to see what each signal means and how it affects the stock.

Unlock signals — free
Expected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74 / 100

About Sanofi Consumer Healthcare India Ltd.

Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India, offering products in the allergy, physical wellness, and pain care segments under brands such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU. The company generates revenue through distributors, wholesalers, government institutions, hospitals, pharmacies, pharmacy chains, and e-commerce platforms. Sanofi Consumer Healthcare India Limited reported a revenue of ₹878 Cr and net income of ₹240 Cr. The company's recent Q4 earnings saw a 50% jump in profit, leading to a 14% surge in its shares. This growth is attributed to the company's strong brand portfolio and effective distribution network. With a dividend of ₹75 declared, Sanofi Consumer Healthcare India Limited is poised fo

Financial Highlights

MetricFY25FY26FY27
Revenue₹676.00 Cr -6.70%₹935.20 Cr +38.30%₹464.90 Cr -50.30%
EBITDA Margin37.43%36.29%40.87%
Net Profit₹168.00 Cr -7.20%₹257.80 Cr +53.50%₹136.60 Cr -47.00%
EPS₹73.08₹111.98₹59.31

Annual figures in Indian Rupees (Crores). Source: BSE filings.

Analyst ConsensusConsensus target ₹5,855.00  |  Buy 1 · Hold 0 · Sell 0Sign in to see →

Strategic Outlook

Growth & Expansion: We expect Sanofi Consumer Healthcare to maintain its strong revenue growth trajectory, driven by the...

Financial Outlook: We expect Sanofi Consumer Healthcare's PAT margin to expand by 150bps YoY in FY27, driven by operatio...

🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instant

Everything you unlock with a free account

Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for SANOFICONR
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track SANOFICONR alongside your other holdings
Unlock full SANOFICONR research — free
No credit card  ·  No trial  ·  Always free to start

Frequently Asked Questions

What AI signals does NiveshIQ provide for Sanofi Consumer Healthcare India Ltd.?

NiveshIQ detects active intelligence signals for Sanofi Consumer Healthcare India Ltd. (SANOFICONR) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.

What are the key financials for Sanofi Consumer Healthcare India Ltd.?

Sanofi Consumer Healthcare India Ltd. operates in the FMCG sector. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.

Does NiveshIQ provide investment advice?

No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.

Viewing preview of Sanofi Consumer Healthcare India Ltd. — 5 active signals detected Unlock full analysis — free